Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast CancerKalnisha Naidoo, Rachael Natrajan, Sarah Maguire et al.|Molecular Cancer Therapeutics|2018Cited by 68